CD274 and neoplasm: In KEYNOTE‐224, higher PD‐L1 immunohistochemistry combined positive scores (a measure of PD‐L1‐positive immune and tumour cells) was associated with better response to treatment with pembrolizumab,79 although this association has not yet been further confirmed.